Emil D. Kakkis
2015
In 2015, Emil D. Kakkis earned a total compensation of $5.4M as President and Chief Executive Officer at Ultragenyx Pharmaceutical, a 673% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $280,875 |
|---|---|
| Option Awards | $3,578,620 |
| Salary | $535,000 |
| Stock Awards | $967,746 |
| Other | $38,419 |
| Total | $5,400,660 |
Kakkis received $3.6M in option awards, accounting for 66% of the total pay in 2015.
Kakkis also received $280.9K in non-equity incentive plan, $535K in salary, $967.7K in stock awards and $38.4K in other compensation.
Rankings
In 2015, Emil D. Kakkis' compensation ranked 1,445th out of 13,638 executives tracked by ExecPay. In other words, Kakkis earned more than 89.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,445 out of 13,638 | 89th |
Division Manufacturing | 509 out of 5,187 | 90th |
Major group Chemicals And Allied Products | 188 out of 1,857 | 90th |
Industry group Drugs | 145 out of 1,531 | 91st |
Industry Pharmaceutical Preparations | 119 out of 1,179 | 90th |
Source: SEC filing on April 28, 2017.
Kakkis' colleagues
We found five more compensation records of executives who worked with Emil D. Kakkis at Ultragenyx Pharmaceutical in 2015.
2015
John Pinion
Ultragenyx Pharmaceutical
Chief Quality Operations Officer and Executive Vice President Analytical Sciences and Research
2015
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
2015
Dennis Huang
Ultragenyx Pharmaceutical
Chief Technical Operations Officer and Senior Vice President
2015
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2015
Thomas Kassberg
Ultragenyx Pharmaceutical